| pubmed-article:20071593 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20071593 | lifeskim:mentions | umls-concept:C0019682 | lld:lifeskim |
| pubmed-article:20071593 | lifeskim:mentions | umls-concept:C0019699 | lld:lifeskim |
| pubmed-article:20071593 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:20071593 | lifeskim:mentions | umls-concept:C0205466 | lld:lifeskim |
| pubmed-article:20071593 | lifeskim:mentions | umls-concept:C0284965 | lld:lifeskim |
| pubmed-article:20071593 | lifeskim:mentions | umls-concept:C0002594 | lld:lifeskim |
| pubmed-article:20071593 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:20071593 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
| pubmed-article:20071593 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:20071593 | pubmed:dateCreated | 2010-1-14 | lld:pubmed |
| pubmed-article:20071593 | pubmed:abstractText | Alanine aminotransferase (ALT) is a routine parameter in the assessment and monitoring of chronic hepatitis C viral (HCV) infection. Hepatitis C virus-infected African Americans (AAs) have been reported to have lower ALT levels. In this retrospective, cross-sectional, multicenter study, host and virological factors possibly associated with ALT levels were analyzed by multivariate regression analyses among HIV/HCV-coinfected patients. Of the 289 patients included, 142 were African Americans and 144 Caucasians. In multivariate analysis, only HCV genotype 3 (B 0.2 [95% CI 13.39-52.33]; P = .001) and HCV RNA >500 000 IU/mL (B 3.1 [95% CI 7.67-34.75]; P = .002) were independent predictors of higher ALT levels. Per the American Association for the Study of Liver Disease (AASLD) definition, 18.2% had ALT levels within normal limits. Male sex and HCV RNA <500 000 IU/mL predicted ALT within normal limits. Hepatitis C viral factors rather than race were associated with ALT levels in this HIV/HCV-coinfected population. ALT were within normal limits in 18% of patients, who more often were male and had lower Hepatitis C viral load. | lld:pubmed |
| pubmed-article:20071593 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20071593 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20071593 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20071593 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20071593 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20071593 | pubmed:issn | 1545-1097 | lld:pubmed |
| pubmed-article:20071593 | pubmed:author | pubmed-author:NúñezMarinaM | lld:pubmed |
| pubmed-article:20071593 | pubmed:author | pubmed-author:MaidaIvanaI | lld:pubmed |
| pubmed-article:20071593 | pubmed:author | pubmed-author:ShoresNathan... | lld:pubmed |
| pubmed-article:20071593 | pubmed:author | pubmed-author:Perez-SalemeL... | lld:pubmed |
| pubmed-article:20071593 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:20071593 | pubmed:volume | 9 | lld:pubmed |
| pubmed-article:20071593 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20071593 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20071593 | pubmed:pagination | 15-9 | lld:pubmed |
| pubmed-article:20071593 | pubmed:meshHeading | pubmed-meshheading:20071593... | lld:pubmed |
| pubmed-article:20071593 | pubmed:meshHeading | pubmed-meshheading:20071593... | lld:pubmed |
| pubmed-article:20071593 | pubmed:meshHeading | pubmed-meshheading:20071593... | lld:pubmed |
| pubmed-article:20071593 | pubmed:meshHeading | pubmed-meshheading:20071593... | lld:pubmed |
| pubmed-article:20071593 | pubmed:meshHeading | pubmed-meshheading:20071593... | lld:pubmed |
| pubmed-article:20071593 | pubmed:meshHeading | pubmed-meshheading:20071593... | lld:pubmed |
| pubmed-article:20071593 | pubmed:meshHeading | pubmed-meshheading:20071593... | lld:pubmed |
| pubmed-article:20071593 | pubmed:meshHeading | pubmed-meshheading:20071593... | lld:pubmed |
| pubmed-article:20071593 | pubmed:meshHeading | pubmed-meshheading:20071593... | lld:pubmed |
| pubmed-article:20071593 | pubmed:meshHeading | pubmed-meshheading:20071593... | lld:pubmed |
| pubmed-article:20071593 | pubmed:meshHeading | pubmed-meshheading:20071593... | lld:pubmed |
| pubmed-article:20071593 | pubmed:meshHeading | pubmed-meshheading:20071593... | lld:pubmed |
| pubmed-article:20071593 | pubmed:meshHeading | pubmed-meshheading:20071593... | lld:pubmed |
| pubmed-article:20071593 | pubmed:meshHeading | pubmed-meshheading:20071593... | lld:pubmed |
| pubmed-article:20071593 | pubmed:meshHeading | pubmed-meshheading:20071593... | lld:pubmed |
| pubmed-article:20071593 | pubmed:meshHeading | pubmed-meshheading:20071593... | lld:pubmed |
| pubmed-article:20071593 | pubmed:meshHeading | pubmed-meshheading:20071593... | lld:pubmed |
| pubmed-article:20071593 | pubmed:meshHeading | pubmed-meshheading:20071593... | lld:pubmed |
| pubmed-article:20071593 | pubmed:meshHeading | pubmed-meshheading:20071593... | lld:pubmed |
| pubmed-article:20071593 | pubmed:articleTitle | Virological rather than host factors are associated with transaminase levels among HIV/HCV-coinfected patients. | lld:pubmed |
| pubmed-article:20071593 | pubmed:affiliation | Division on Gastroenterology, Department of Internal Medicine, Wake Forest University Health Sciences, Winston-Salem, NC 27157, USA. | lld:pubmed |
| pubmed-article:20071593 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20071593 | pubmed:publicationType | Multicenter Study | lld:pubmed |
